Investor Materials Sample Clauses

Investor Materials. This Questionnaire is intended to assess interest in participation in the offering of common stocks of American Housing Income Trust, Inc. (the “Company”) through the exercise of an option to acquire the shares through a 721 exchange with the Company’s umbrella partnership – AHIT Northern NM Properties, LLP. We ask that you please complete and return this Questionnaire at the time of Closing under the Contribution Agreement. This questionnaire is not intended to be, and does not constitute, an offer to sell or the solicitation of an offer to buy any security. No binding agreement or obligation of any kind shall be created by this questionnaire. Participation in the Offering is available only to “accredited investors.” Please refer to the definitions below. Please place an “X” in the appropriate box below to indicate your status (ONLY ONE BOX NEEDS TO BE CHECKED; CONTACT THE COMPANY IF NONE IS APPLICABLE): “Accredited investor” means any person who comes within any of the following categories:
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Investor Materials. Each Seller, on or before ten (10) days after the date of this Agreement, shall complete a questionnaire (in substantially the form set forth in Exhibit "Investor Materials" attached hereto, the "Investor Materials") providing, among other things, information concerning each Seller's status as an Accredited Investor, and shall provide or cause to be provided to Buyer, or to any other party designated by Buyer, such other information and documentation as may reasonably be requested by Buyer in furtherance of the issuance of the Shares as contemplated hereby. Notwithstanding anything contained in this Agreement to the contrary, in the event that, in the reasonable opinion of Buyer, based on advice of its securities counsel, (x) any such person or entity providing Investor Materials is not considered an Accredited Investor, (y) the proposed delivery of Shares hereunder might not qualify for the exemption from the registration requirements of Section 5 of the Securities Act, or (z) the proposed delivery of Shares hereunder would violate any applicable federal or state securities laws, rules or regulations, or agreements to which the REIT or the Buyer is a party, or any tax related or other legal rules, agreements or constraints applicable to Buyer or the REIT, Buyer shall so advise Seller, in writing (the "Regulatory Violation Notice") within five (5) business days after such determination is made. In the event a Regulatory Violation Notice is delivered, this Agreement shall terminate and no party shall have any further liability hereunder except (i) as otherwise expressly set forth in this Agreement and (ii) to the extent a breach of this Agreement gives rise to, or becomes the basis for, the Regulatory Violation Notice.
Sample 1Sample 2
Investor Materials. It is your responsibility to read all disclosures, statements, prospectuses, mutual fund shareholder documents, proxy statements, shareholder reports, and other similar documents (the “Documents”), delivered by SoFi Securities or any issuer of securities in your Account, and to take any action appropriate in response to information or instructions contained in such Documents. SoFi Securities is not responsible for any loss sustained by you caused by your failure to review and act in a timely manner in response to directions or information contained in Documents properly delivered to you.
Sample 1
Investor Materials. In connection with the Offering of the Securities, the Offering will be made by means of certain documents and materials to be prepared and approved by the Company in consultation with CDC (collectively, "Investor Materials"). Such Investor Materials will be provided by the Company to CDC in advance, and no such documents or materials will be provided to investors introduced to the Company by CDC without CDC's prior approval; provided that the Company will be solely and ultimately responsible for the contents of the Investor Materials and all other information forwarded to prospective purchasers of the Securities by or on behalf of the Company. CDC will not provide any additional documents or materials to prospective purchasers unless directed in writing by the Company on its behalf. The Investor Materials, as well as any registration statement covering the resale of the Securities, shall be the responsibility of the Company. The Investor Materials will include all information to be provided to investors under Regulation D under the Securities Act of 1933, as amended (the "Securities Act"), and under antifraud laws and regulations contained in applicable federal and state securities laws, and any registration statement covering the resale of the Securities shall likewise comply with all applicable federal and state securities laws. The Company represents and warrants that neither the Investor Materials, the SEC Documents (as defined below), the Subscription Agreements (as defined below) nor any registration statement shall contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. CDC will keep strict control over the disposition of each copy of the Investor Materials.
Sample 1
Investor Materials. During the distribution of the Units, the Company will not provide any potential investor with any materials or information in relation to the distribution of the Units or the Company other than the Prospectuses and any amendments or supplements thereto in accordance with this Agreement, provided that: (A) any such materials that constitute marketing materials have been approved and filed in accordance with Section 3.27 hereof; and (B) any such materials that constitute “standard term sheets” have been approved in writing by the Company and the Underwriters and are provided in compliance with Canadian Securities Laws.
Sample 1

Related to Investor Materials

  • Other Materials On each date on which the Company is required to deliver a certificate pursuant to Section 7(l), the Company shall have furnished to the Agent such appropriate further information, opinions, certificates, letters and other documents as the Agent may reasonably request. All such opinions, certificates, letters and other documents will be in compliance with the provisions hereof.

  • Offering Materials Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to each Closing Date, any offering material in connection with the offering and sale of the Securities other than the Time of Sale Disclosure Package.

  • Technical Information The Employer agrees to provide to the Union such information that is available relating to employees in the bargaining unit, as may be required by the Union for collective bargaining purposes.

  • Proprietary Materials Each of the Parties shall own its own intellectual property including without limitation all trade secrets, know-how, proprietary data, documents, and written materials in any format. Any materials created exclusively by IPS for the School shall be owned by IPS, and any materials created exclusively by Operator for the School shall be Operator’s proprietary material. The Parties acknowledge and agree that neither has any intellectual property interest or claims in the other Party’s proprietary materials. Notwithstanding the foregoing, materials and work product jointly created by the Parties shall be jointly owned by the Parties and may be used by the individual Party as may be agreed upon by both Parties from time to time.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Company Materials During the term of this Agreement, the Company agrees to furnish the Manager at its principal office all prospectuses, proxy statements, reports to shareholders, sales literature or other material prepared for distribution to shareholders of the Funds or to the public, which refer to the Manager in any way, prior to use thereof and, not to use such material if the Manager reasonably objects in writing within five business days (or such other time as may be mutually agreed) after receipt thereof. In the event of termination of this Agreement, the Company will continue to furnish to the Manager copies of any of the above-mentioned materials which refer in any way to the Manager. The Company shall furnish or otherwise make available to the Manager such other information relating to the business affairs of the Funds as the Manager at any time, or from time to time, reasonably requests in order to discharge its obligations hereunder.

  • Press Release; Public Offering Materials Disclose the name of Agent or any Lender in any press release or in any prospectus, proxy statement or other materials filed with any governmental entity relating to a public offering of the capital stock of any Loan Party except as may be required by law.

  • Marketing Materials (a) During the term of this Agreement, the Sub-Adviser agrees to furnish the Manager at its principal office for prior review and approval by the Manager all written and/or printed materials, including but not limited to, PowerPointÒ or slide presentations, news releases, advertisements, brochures, fact sheets and other promotional, informational or marketing materials (the “Marketing Materials”) for internal use or public dissemination, that are produced or are for use or reference by the Sub-Adviser, its affiliates or other designees, broker-dealers or the public in connection with the Series, and Sub-Adviser shall not use any such materials if the Manager reasonably objects in writing within five business days (or such other period as may be mutually agreed) after receipt thereof. Marketing Materials may be furnished to the Manager by first class or overnight mail, facsimile transmission equipment, electronic delivery or hand delivery.

  • KYC Information (i) Upon the reasonable request of any Lender made at least five (5) days prior to the Closing Date, the Borrowers shall have provided to such Lender, and such Lender shall be reasonably satisfied with, the documentation and other information so requested in connection with applicable “know your customer” and anti-money-laundering rules and regulations, including, without limitation, the PATRIOT Act, in each case at least five (5) days prior to the Closing Date.

  • Rule 144 Information The Company covenants that it will use its reasonable best efforts to timely file all reports and other documents required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations promulgated by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request of any Warrantholder, make publicly available such information as necessary to permit sales pursuant to Rule 144 under the Securities Act), and it will use reasonable best efforts to take such further action as any Warrantholder may reasonably request, in each case to the extent required from time to time to enable such holder to, if permitted by the terms of this Warrant and the Purchase Agreement, sell this Warrant without registration under the Securities Act within the limitation of the exemptions provided by (A) Rule 144 under the Securities Act, as such rule may be amended from time to time, or (B) any successor rule or regulation hereafter adopted by the SEC. Upon the written request of any Warrantholder, the Company will deliver to such Warrantholder a written statement that it has complied with such requirements.

Time is Money Join Law Insider Premium to draft better contracts faster.